NCT01429675View on ClinicalTrials.gov

Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

March 31, 2012

Conditions
Healthy
Interventions
DRUG

bonviva

150mg Ibandronate once a month

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

Alvogen Korea
All Listed Sponsors
lead

Alvogen Korea

INDUSTRY

NCT01429675 - Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter